TY - JOUR
T1 - Prescription Drug Monitoring Programs
T2 - Ethical Issues in the Emergency Department
AU - ACEP Ethics Committee
AU - ACEP Ethics Committee
AU - Marco, Catherine A.
AU - Venkat, Arvind
AU - Baker, Eileen F.
AU - Jesus, John E.
AU - Geiderman, Joel M.
AU - Geiderman, Joel M.
AU - Friedman, Vidor
AU - Allen, Nathan G.
AU - Aswegan, Andrew L.
AU - Baker, Eileen F.
AU - Bookman, Kelly
AU - Brenner, Jay M.
AU - Delpier, Michelle Y.
AU - Derse, Arthur R.
AU - DeSandre, Paul L.
AU - Donahue, Brian B.
AU - Fairbrother, Hilary E.
AU - Iserson, Kenneth V.
AU - Jesus, John E.
AU - Kluesner, Nicholas H.
AU - Knowles, Heidi C.
AU - Kraus, Chadd K.
AU - Larkin, Gregory L.
AU - Limehouse, Walter E.
AU - Marco, Catherine A.
AU - McGrath, Norine A.
AU - Moskop, John
AU - Nadeem, Shehni
AU - Phillips, Elizabeth M.
AU - Rosenberg, Mark S.
AU - Schears, Raquel M.
AU - Shah, Sachin J.
AU - Simon, Jeremy
AU - Solomon, Robert C.
AU - Venkat, Arvind
AU - Wang, David
AU - Moore, Leslie
N1 - Publisher Copyright:
© 2016 American College of Emergency Physicians
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Prescription drug monitoring programs are statewide databases available to clinicians to track prescriptions of controlled medications. These programs may provide valuable information to assess the history and use of controlled substances and contribute to clinical decisionmaking in the emergency department (ED). The widespread availability of the programs raises important ethical issues about beneficence, nonmaleficence, respect for persons, justice, confidentiality, veracity, and physician autonomy. In this article, we review the ethical issues surrounding prescription drug monitoring programs and how those issues might be addressed to ensure the proper application of this tool in the ED. Clinical decisionmaking in regard to the appropriate use of opioids and other controlled substances is complex and should take into account all relevant clinical factors, including age, sex, clinical condition, medical history, medication history and potential drug-drug interactions, history of addiction or diversion, and disease state.
AB - Prescription drug monitoring programs are statewide databases available to clinicians to track prescriptions of controlled medications. These programs may provide valuable information to assess the history and use of controlled substances and contribute to clinical decisionmaking in the emergency department (ED). The widespread availability of the programs raises important ethical issues about beneficence, nonmaleficence, respect for persons, justice, confidentiality, veracity, and physician autonomy. In this article, we review the ethical issues surrounding prescription drug monitoring programs and how those issues might be addressed to ensure the proper application of this tool in the ED. Clinical decisionmaking in regard to the appropriate use of opioids and other controlled substances is complex and should take into account all relevant clinical factors, including age, sex, clinical condition, medical history, medication history and potential drug-drug interactions, history of addiction or diversion, and disease state.
UR - http://www.scopus.com/inward/record.url?scp=84966703623&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84966703623&partnerID=8YFLogxK
U2 - 10.1016/j.annemergmed.2016.04.018
DO - 10.1016/j.annemergmed.2016.04.018
M3 - Review article
C2 - 27181079
AN - SCOPUS:84966703623
SN - 0196-0644
VL - 68
SP - 589
EP - 598
JO - Annals of Emergency Medicine
JF - Annals of Emergency Medicine
IS - 5
ER -